Literature DB >> 24375404

The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruption.

Wakana Ono1, Yuki Hayashi, Wataru Yokoyama, Takao Kuroda, Hiroyuki Kishimoto, Ichiaki Ito, Keiji Kimura, Kensuke Akaogi, Tsuyoshi Waku, Junn Yanagisawa.   

Abstract

Tetramerization of p53 is crucial to exert its biological activity, and nucleolar disruption is sufficient to activate p53. We previously demonstrated that nucleolar stress induces translocation of the nucleolar protein MYBBP1A from the nucleolus to the nucleoplasm and enhances p53 activity. However, whether and how MYBBP1A regulates p53 tetramerization in response to nucleolar stress remain unclear. In this study, we demonstrated that MYBBP1A enhances p53 tetramerization, followed by acetylation under nucleolar stress. We found that MYBBP1A has two regions that directly bind to lysine residues of the p53 C-terminal regulatory domain. MYBBP1A formed a self-assembled complex that provided a molecular platform for p53 tetramerization and enhanced p300-mediated acetylation of the p53 tetramer. Moreover, our results show that MYBBP1A functions to enhance p53 tetramerization that is necessary for p53 activation, followed by cell death with actinomycin D treatment. Thus, we suggest that MYBBP1A plays a pivotal role in the cellular stress response.

Entities:  

Keywords:  Cell Death; Nucleolus; Post-translational Modification; Stress Response; p300; p53

Mesh:

Substances:

Year:  2013        PMID: 24375404      PMCID: PMC3931054          DOI: 10.1074/jbc.M113.474049

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 2.  p53 and human cancer: the first ten thousand mutations.

Authors:  P Hainaut; M Hollstein
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

3.  Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization.

Authors:  A Saxena; C J Rorie; D Dimitrova; Y Daniely; J A Borowiec
Journal:  Oncogene       Date:  2006-06-05       Impact factor: 9.867

4.  Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.

Authors:  Mu-Shui Dai; Xiao-Xin Sun; Hua Lu
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

Review 5.  p53 ubiquitination: Mdm2 and beyond.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

6.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

7.  Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.

Authors:  Mu-Shui Dai; Shelya X Zeng; Yetao Jin; Xiao-Xin Sun; Larry David; Hua Lu
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Epigenetic control of rDNA loci in response to intracellular energy status.

Authors:  Akiko Murayama; Kazuji Ohmori; Akiko Fujimura; Hiroshi Minami; Kayoko Yasuzawa-Tanaka; Takao Kuroda; Shohei Oie; Hiroaki Daitoku; Mitsuru Okuwaki; Kyosuke Nagata; Akiyoshi Fukamizu; Keiji Kimura; Toshiyuki Shimizu; Junn Yanagisawa
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

9.  Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses.

Authors:  Carlos P Rubbi; Jo Milner
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

10.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

Authors:  T Kamijo; J D Weber; G Zambetti; F Zindy; M F Roussel; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more
  16 in total

Review 1.  Role of the nucleus in apoptosis: signaling and execution.

Authors:  Evgeniia A Prokhorova; Alexey V Zamaraev; Gelina S Kopeina; Boris Zhivotovsky; Inna N Lavrik
Journal:  Cell Mol Life Sci       Date:  2015-09-07       Impact factor: 9.261

Review 2.  The protein-interaction network with functional roles in tumorigenesis, neurodegeneration, and aging.

Authors:  Jarmila Nahálková
Journal:  Mol Cell Biochem       Date:  2016-10-03       Impact factor: 3.396

3.  Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer.

Authors:  Xiao Ling Li; Murugan Subramanian; Matthew F Jones; Ritu Chaudhary; Deepak K Singh; Xinying Zong; Berkley Gryder; Sivasish Sindri; Min Mo; Aaron Schetter; Xinyu Wen; Swetha Parvathaneni; Dickran Kazandjian; Lisa M Jenkins; Wei Tang; Fathi Elloumi; Jennifer L Martindale; Maite Huarte; Yuelin Zhu; Ana I Robles; Susan M Frier; Frank Rigo; Maggie Cam; Stefan Ambs; Sudha Sharma; Curtis C Harris; Mary Dasso; Kannanganattu V Prasanth; Ashish Lal
Journal:  Cell Rep       Date:  2017-09-05       Impact factor: 9.423

4.  Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation.

Authors:  Junnan Liang; Ganxun Li; Jingyu Liao; Zhao Huang; Jingyuan Wen; Yu Wang; Zeyu Chen; Guangzhen Cai; Weiqi Xu; Zeyang Ding; Huifang Liang; Pran K Datta; Liang Chu; Xiaoping Chen; Bixiang Zhang
Journal:  Cell Death Differ       Date:  2022-01-15       Impact factor: 12.067

5.  p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis.

Authors:  Nicholas W Fischer; Aaron Prodeus; David Malkin; Jean Gariépy
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

6.  Gradual reduction in rRNA transcription triggers p53 acetylation and apoptosis via MYBBP1A.

Authors:  Takuya Kumazawa; Kazuho Nishimura; Naohiro Katagiri; Sayaka Hashimoto; Yuki Hayashi; Keiji Kimura
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

7.  p53- and ERK7-dependent ribosome surveillance response regulates Drosophila insulin-like peptide secretion.

Authors:  Kiran Hasygar; Ville Hietakangas
Journal:  PLoS Genet       Date:  2014-11-13       Impact factor: 5.917

8.  Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo.

Authors:  Li Lu; Ke Li; Yun-Hua Mao; Hu Qu; Bing Yao; Wen-Wen Zhong; Bo Ma; Zhong-Yang Wang
Journal:  Int J Oncol       Date:  2017-08-10       Impact factor: 5.650

9.  Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers.

Authors:  Gregory W Schwartz; Jelena Petrovic; Yeqiao Zhou; Robert B Faryabi
Journal:  Front Genet       Date:  2018-06-15       Impact factor: 4.599

10.  p38-MAPK-mediated translation regulation during early blastocyst development is required for primitive endoderm differentiation in mice.

Authors:  Pablo Bora; Lenka Gahurova; Tomáš Mašek; Andrea Hauserova; David Potěšil; Denisa Jansova; Andrej Susor; Zbyněk Zdráhal; Anna Ajduk; Martin Pospíšek; Alexander W Bruce
Journal:  Commun Biol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.